Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Rhabdomyolysis during therapy with daptomycin.

Literature DB >> 16705566

Rhabdomyolysis during therapy with daptomycin.

Stella Papadopoulos¹, Amanda M Ball, Susanne E Liewer, Craig A Martin, P Shane Winstead, Brian S Murphy.

Abstract

The use of daptomycin has been associated with an elevation in creatine phosphokinase level, with a reported incidence of 2.8% in phase III clinical trials. Published case reports have documented the presence of myopathy in patients who received daptomycin; however, there have been no previously reported cases of rhabdomyolysis in animals or humans to date. We describe a case of rhabdomyolysis during therapy with daptomycin.

Entities: Chemical Disease Species

Mesh：

Substances：

Year: 2006 PMID： 16705566 DOI： 10.1086/504379

Source DB: PubMed Journal: Clin Infect Dis ISSN： 1058-4838 Impact factor: 9.079

Keyword Cloud
Cited

20 in total

1. [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].

Authors: D C Richter; T Brenner; A Brinkmann; B Grabein; M Hochreiter; A Heininger; D Störzinger; J Briegel; M Pletz; M A Weigand; C Lichtenstern
Journal: Anaesthesist Date: 2019-10 Impact factor: 1.041

2. Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections.

Authors: Noreen H Chan Tompkins; Stephen J Harnicar
Journal: P T Date: 2008-05

3. [Rational antibiotic therapy in ophthalmology].

Authors: W Behrens-Baumann; U Frank; T Ness
Journal: Ophthalmologe Date: 2010-04 Impact factor: 1.059

4. Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Authors: Camelia E Marculescu; Elie F Berbari; J Robert Cantey; Douglas R Osmon
Journal: Mayo Clin Proc Date: 2012-01 Impact factor: 7.616

Review 5. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.

Authors: Michael J Satlin; Thomas J Walsh
Journal: Transpl Infect Dis Date: 2017-10-25 Impact factor: 2.228

6. A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

Authors: C Rether; A Conen; M Grossenbacher; W C Albrich
Journal: Infection Date: 2011-06-30 Impact factor: 3.553

Rhabdomyolysis during therapy with daptomycin.

1. [Infections due to multidrug-resistant pathogens : Pathogens, resistance mechanisms and established treatment options].

2. Prescribing trends with daptomycin (cubicin) for the treatment of gram-positive infections.

3. [Rational antibiotic therapy in ophthalmology].

4. Practical considerations in the use of outpatient antimicrobial therapy for musculoskeletal infections.

Review 5. Multidrug-resistant Enterobacteriaceae, Pseudomonas aeruginosa, and vancomycin-resistant Enterococcus: Three major threats to hematopoietic stem cell transplant recipients.

6. A rare cause of pulmonary infiltrates one should be aware of: a case of daptomycin-induced acute eosinophilic pneumonia.

7. The emergence of vancomycin-resistant enterococcal bacteremia in hematopoietic stem cell transplant recipients.

Review 8. Clinical management of septic arthritis.

9. Treatment of community-associated methicillin-resistant Staphylococcus aureus.

10. Treatment of community-associated methicillin-resistant Staphylococcus aureus.